BIOT.L
BIOT.L
L&G Pharma Breakthrough UCITS ETF • L&G
$13.54 ▼ -1.76% (-0.24)
Managing Company L&G
Asset Under Management $19.50M
Inception Date Jan 23, 2018
Expense Ratio 0.49%
52w High $14.34
52w Low $8.96
Volume 2,866
Avg Volume 1,482
Asset Class Equity
About L&G Pharma Breakthrough UCITS ETF
The L&G Pharma Breakthrough UCITS ETF (the Fund) is an exchange traded fund (ETF) that aims to track the performance of the Solactive Pharma Breakthrough Value Index Net Total Return (the Index) subject to the deduction of the ongoing charges and other costs associated with operating the Fund.
Managing Company L&G
Asset Under Management $19.50M
Inception Date Jan 23, 2018
Expense Ratio 0.49%
52w High $14.34
52w Low $8.96
Volume 2,866
Avg Volume 1,482
Asset Class Equity
About L&G Pharma Breakthrough UCITS ETF
The L&G Pharma Breakthrough UCITS ETF (the Fund) is an exchange traded fund (ETF) that aims to track the performance of the Solactive Pharma Breakthrough Value Index Net Total Return (the Index) subject to the deduction of the ongoing charges and other costs associated with operating the Fund.
HOLDINGS (Top 20)
No holdings data available.
SECTOR HOLDINGS
Healthcare
Basic MaterialsASSET ALLOCATION BY REGION
United States
Japan
Netherlands
Switzerland
China
Australia
Sweden
South Korea
Denmark
France
Spain Other
0.21%SECTOR HOLDINGS
Healthcare Basic MaterialsASSET ALLOCATION BY REGION
United States Japan Netherlands Switzerland China Australia Sweden South Korea Denmark France Spain Other
0.21%Holdings (Top 20)
No holdings data available.